An AI protein-design biotech combining machine learning with physical principles to engineer de novo antibodies and other therapeutic proteins.
Seoul National University / Galux
Released May 15, 2025
T-cell epitope immunogenicity prediction that fuses MHC presentation, TCR binding, and activation data via adversarial multi-domain pretraining.